SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Pulmonology Consultation — Leonard Nimoy — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientLeonard Nimoy
Date of birth1931-03-26
IdentifiersMRN HR-ML017-SYN-TD; SSN (made up) 000-17-6604
Document date2014-03-10
AuthorOwen Rasmussen, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

COPD in an 82-year-old former smoker, now confirmed on spirometry as GOLD 3. Please confirm the grade and group, review the inhaler choice and the place of an inhaled corticosteroid, assess his oxygen needs, and advise on pulmonary rehabilitation and lung cancer screening. [S]

Urgency: Routine, within four weeks. [S]

Questions for the consultant:

History of Present Illness

Mr. Nimoy is seen at the request of Dr. Benedetti four weeks after starting tiotropium-olodaterol. He smoked heavily for many years, quit about 30 years ago through a cessation program, and has been limited by breathlessness for some time. He now stops after about 100 meters on level ground. His mornings are a little easier on the new inhaler, and his albuterol use has fallen to about four times a week. He has little cough, a small amount of clear morning sputum, and no wheeze at rest, chest pain, orthopnea, ankle swelling, snoring, or reflux. He has had no exacerbation in the past year. He is keen to keep active and to warn others about smoking. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Albuterol 90 mcg/actuation inhaler, two inhalations as needed for breathlessness (prescribed by his previous clinician; used once or twice most days before intake)Two inhalations every 4 hours as needed, with a spacerRespiratory tract route2013-09-15activeS
Tiotropium-olodaterol 2.5/2.5 mcg soft mist inhaler, two inhalations once dailyTwo inhalations once each morningRespiratory tract route2014-02-10activeS

Problems

ProblemClinical statusVerificationCodeProvenance
Chronic obstructive pulmonary disease, GOLD 3 (severe airflow limitation), group B, confirmed on spirometry; synthetic modern classification linked to his publicly disclosed COPDactiveconfirmed J44.9S — Synthetic modern spirometric classification; the COPD diagnosis itself is D from his own public disclosure.
Former smoker, quit about 30 years ago through a cessation programactiveconfirmed Z87.891S — Synthetic modern entry linked to his public account of quitting smoking.

Physical Exam

Vital signs recorded on 2014-03-10; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralTall man, comfortable at rest, speaking in full sentences
ChestHyperinflated; reduced breath sounds throughout with prolonged expiration; no wheeze or crackles
CardiovascularRegular rhythm; no murmur; no raised jugular venous pressure or edema
ExtremitiesNo clubbing or cyanosis
Inhaler techniqueCorrect with the soft mist inhaler

Results

DateMeasureValueUnitReference rangeFlagProvenance
2014-03-10Six minute walk test270mPredicted about 480 m for his age, sex, height, and weight; lower limit about 380 mLowS

Assessment

Data reviewed: Intake spirometry before and after bronchodilator, the blood eosinophil count, the alpha-1 antitrypsin level, hemoglobin, creatinine, the intake ECG, the CAT and mMRC scores, and today's 6-minute walk test with continuous oximetry. [S]

Plan of Treatment